O-GlcNAcylation in novel regulated cell death: ferroptosis, pyroptosis, and necroptosis

Ying-Zi Wang1,2, Hao-Yu Zhao1,2, Tashi Nyima3

  • 1The First Affiliated Hospital of Yangtze University, Yangtze University, Jingzhou, Hubei, China.

Cell Death Discovery
|December 5, 2025
PubMed

Insights

O-GlcNAcylation regulates cell death pathways like ferroptosis, pyroptosis, and necroptosis. Targeting this modification offers therapeutic potential for diseases involving abnormal cell death.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Medicine

Background:

  • O-GlcNAcylation is a dynamic post-translational modification crucial for cellular metabolism and signaling.
  • Ferroptosis, pyroptosis, and necroptosis are key regulated cell death pathways implicated in numerous diseases.
  • Dysregulated cell death contributes to pathologies such as cancer, neurodegeneration, and inflammation.

Purpose of the Study:

  • To review the role of O-GlcNAcylation in modulating ferroptosis, pyroptosis, and necroptosis.
  • To explore the implications of O-GlcNAcylation in disease mechanisms.
  • To discuss the therapeutic potential of targeting O-GlcNAcylation for diseases with aberrant cell death.

Main Methods:

  • Literature review of O-GlcNAcylation and regulated cell death pathways.
  • Analysis of molecular mechanisms linking O-GlcNAcylation to ferroptosis, pyroptosis, and necroptosis.
  • Synthesis of current research on therapeutic strategies targeting O-GlcNAcylation.

Main Results:

  • O-GlcNAcylation significantly influences the induction and execution of ferroptosis, pyroptosis, and necroptosis.
  • Specific O-GlcNAcylation targets and their impact on cell death signaling are identified.
  • Evidence suggests O-GlcNAcylation plays a dual role, promoting or inhibiting cell death depending on context.

Conclusions:

  • O-GlcNAcylation is a critical regulator of distinct programmed cell death pathways.
  • Understanding these regulatory mechanisms provides insights into disease pathogenesis.
  • Targeting O-GlcNAcylation presents a promising therapeutic avenue for managing diseases characterized by abnormal cell death.

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.3K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.2K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.3K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.0K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
4.9K